Which has the lower trailing P/E, BIIB or IDXX?

IDXX has the lower trailing P/E: BIIB trades at 38.01 and IDXX at 36.26. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or IDXX?

Over the past five years, IDXX grew revenue faster — BIIB at a -3.19% CAGR versus IDXX at 8.37%.

Is BIIB or IDXX more profitable?

IDXX runs the higher net margin — BIIB at 8.39% versus IDXX at 25.03%.

How have BIIB and IDXX total returns compared?

Over the past 10 years, BIIB delivered -3.34% and IDXX delivered 16.70% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of Biogen Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$31.73B

$214.78HealthcareDelayed quote: Sep 10, 2026, 10:15 AM EDT

IDXX

IDEXX Laboratories, Inc.

$40.39B

$512.00HealthcareDelayed quote: Sep 10, 2026, 10:15 AM EDT

Total return — BIIB vs IDXX

growth of $100 · dividends reinvested · last 10y

BIIB -32.5% (-3.9%/yr)IDXX +370.3% (+16.7%/yr)IDXX compounded faster over this window

Log scale — wide-divergence pair

BIIB IDXX

BIIB vs IDXX: by the numbers

•IDXX is the larger company ($40.39B vs $31.73B market cap).
•IDXX trades at the lower trailing earnings multiple (36.26 vs 38.01 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (25.03% vs 8.39% net margin).
•IDXX grew revenue faster over the past five years (8.37% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	IDXX
P/E ratio	38.01	36.26
Forward P/E	17.20	34.66
P/S ratio	3.19	8.87
P/B ratio	1.68	25.05
EV / EBITDA	N/A	25.60
FCF yield	8.50%	3.10%

Profitability

Metric	BIIB	IDXX
Gross margin	67.71%	62.45%
Operating margin	12.79%	32.03%
Net margin	8.39%	25.03%
ROE	4.43%	70.67%
ROIC	4.28%	41.33%

Growth (annualized)

Metric	BIIB	IDXX
Revenue CAGR (5Y)	-3.19%	8.37%
EPS CAGR (5Y)	-18.67%	14.07%
FCF CAGR (5Y)	-11.63%	12.49%
Total return CAGR (5Y)	-6.83%	-5.31%

Frequently asked

Which has the lower trailing P/E, BIIB or IDXX?: IDXX has the lower trailing P/E: BIIB trades at 38.01 and IDXX at 36.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or IDXX?: Over the past five years, IDXX grew revenue faster — BIIB at a -3.19% CAGR versus IDXX at 8.37%.
Is BIIB or IDXX more profitable?: IDXX runs the higher net margin — BIIB at 8.39% versus IDXX at 25.03%.
How have BIIB and IDXX total returns compared?: Over the past 10 years, BIIB delivered -3.34% and IDXX delivered 16.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio IDEXX Laboratories P/E ratio Biogen ROE IDEXX Laboratories ROE Biogen operating margin IDEXX Laboratories operating margin Biogen revenue growth IDEXX Laboratories revenue growth Biogen free cash flow IDEXX Laboratories free cash flow

Biogen & IDEXX Laboratories appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.